MAM-2201
跳至導覽
跳至搜尋
| File:MAM-2201 structure.png | |
| 法律規範狀態 | |
|---|---|
| 法律規範 | |
| 識別資訊 | |
| |
| CAS號 | 1354631-24-5 check |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| E編碼 | {{#property:P628}} |
| CompTox Dashboard (EPA) |
|
| ECHA InfoCard | {{#property:P2566}}Module:EditAtWikidata第29行Lua錯誤:attempt to index field 'wikibase' (a nil value) |
| 化學資訊 | |
| 化學式 | C25H24FNO |
| 摩爾質量 | 373.47 g·mol−1 |
| 3D模型(JSmol) | |
| |
| |
MAM-2201,化學名1-(5-氟戊基)-3-(4-甲基-1-萘甲酰基)吲哚,也稱為4'-methyl-AM-2201、5"-fluoro-JWH-122)是一種含氮有機氟化合物,化學式C
25H
24FNO,屬於萘甲酰基吲哚類合成大麻素[2][3],2015年列入《非藥用類麻醉藥品和精神藥品名錄》[4]。
參考文獻[編輯]
- ^ Anvisa. RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial [Collegiate Board Resolution No. 804 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control]. Diário Oficial da União. 2023-07-24 (2023-07-25) [2023-08-27]. (原始內容存檔於2023-08-27) (português do Brasil).
- ^ Zaitsu K, Nakayama H, Yamanaka M, Hisatsune K, Taki K, Asano T, et al. High-resolution mass spectrometric determination of the synthetic cannabinoids MAM-2201, AM-2201, AM-2232, and their metabolites in postmortem plasma and urine by LC/Q-TOFMS. International Journal of Legal Medicine. November 2015, 129 (6): 1233–45. PMID 26349566. S2CID 24905067. doi:10.1007/s00414-015-1257-4.
- ^ Kim JH, Kong TY, Moon JY, Choi KH, Cho YY, Kang HC, et al. Targeted and non-targeted metabolite identification of MAM-2201 in human, mouse, and rat hepatocytes. Drug Testing and Analysis. April 2018, 10 (8): 1328–1335. PMID 29608249. doi:10.1002/dta.2389.
- ^ 連結至維基文庫 关于印发《非药用类麻醉药品和精神药品列管办法》的通知. 維基文庫. 公安部 國家衛生計生委 食品藥品監管總局 國家禁毒辦. 24 9 2015 (中文).